The maternal embryonic leucine zipper kinase (MELK) is upregulated in high-grade prostate cancer (Q39286062)

10 September 2017

The maternal embryonic leucine zipper kinase (MELK) is upregulated in high-grade prostate cancer (English)

1 reference

10 September 2017

1 reference

8

Georg Schäfer

1 reference

10 September 2017

Ruprecht Kuner

1

1 reference

10 September 2017

Maria Fälth

2

1 reference

10 September 2017

Nicole Chui Pressinotti

3

1 reference

10 September 2017

Jan C Brase

4

1 reference

10 September 2017

Sabrina Balaguer Puig

5

1 reference

10 September 2017

Jennifer Metzger

6

1 reference

10 September 2017

Stephan Gade

7

1 reference

10 September 2017

Georg Bartsch

9

1 reference

10 September 2017

Eberhard Steiner

10

1 reference

10 September 2017

Helmut Klocker

11

1 reference

10 September 2017

Holger Sültmann

12

1 reference

10 September 2017

4 September 2012

1 reference

Journal of Molecular Medicine

10 September 2017

1 reference

10 September 2017

91

1 reference

10 September 2017

2

1 reference

10 September 2017

237-248

1 reference

https://scigraph.springernature.com/pub.10.1007/s00109-012-0949-1

10 September 2017

0 references

cites work

Prostate cancer screening: current status and future perspectives.

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0949-1

Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0949-1

Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0949-1

Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0949-1

Maternal embryonic leucine zipper kinase/murine protein serine-threonine kinase 38 is a promising therapeutic target for multiple cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0949-1

Maternal embryonic leucine zipper kinase transcript abundance correlates with malignancy grade in human astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0949-1

Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0949-1

Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0949-1

Siomycin A targets brain tumor stem cells partially through a MELK-mediated pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0949-1

A functional analysis of MELK in cell division reveals a transition in the mode of cytokinesis during Xenopus development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0949-1

Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0949-1

Maternal embryonic leucine zipper kinase (MELK) regulates multipotent neural progenitor proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0949-1

Maternal embryonic leucine zipper kinase is upregulated and required in mammary tumor-initiating cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0949-1

Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0949-1

Prostate-specific antigen testing in Tyrol, Austria: prostate cancer mortality reduction was supported by an update with mortality data up to 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0949-1

The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0949-1

lumi: a pipeline for processing Illumina microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0949-1

GOstat: find statistically overrepresented Gene Ontologies within a group of genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0949-1

Integrative genomic profiling of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0949-1

Differential expression of apoptotic genes PDIA3 and MAP3K5 distinguishes between low- and high-risk prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0949-1

A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0949-1

Clinical implications of changing definitions within the Gleason grading system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0949-1

mRNA expression signature of Gleason grade predicts lethal prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0949-1

TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0949-1

Cell proliferation, apoptosis, oncogene, and tumor suppressor gene status in adenosis with comparison to benign prostatic hyperplasia, prostatic intraepithelial neoplasia, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0949-1

Ubiquitination by the anaphase-promoting complex drives spindle checkpoint inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0949-1

M-phase MELK activity is regulated by MPF and MAPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0949-1

Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0949-1

Gene networks and microRNAs implicated in aggressive prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0949-1

Expression of Melk, a new protein kinase, during early mouse development

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22945237

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Linear models and empirical bayes methods for assessing differential expression in microarray experiments

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22945237

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

New potential anti-cancer agents synergize with bortezomib and ABT-737 against prostate cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22945237

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00109-012-0949-1

1 reference

release_v2ncekye3remfpi3f4alpvnqsq

10 September 2017

0 references

1 reference